Effect of nucleotide P2Y2 receptor agonists on outward active transport of fluorescein across normal blood-retina barrier in rabbit

Experimental Eye Research

Volumn 78, Issue 1, 2004, Pages 103-108

  Takahashi, Junichi ^a   Hikichi, Taiichi ^a   Mori, Fumihiko ^a   Kawahara, Atsushi ^a   Yoshida, Akitoshi ^a   Peterson, Ward M ^b  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Blood retinal barrier; Differential vitreous fluorophotometry; Outward active transport; P2Y2 receptor agonist; Retinal pigment epithelium

Indexed keywords

BUFFER; FLUORESCEIN; FLUORESCEIN GLUCURONIDE; INS 542; PURINE P2Y2 RECEPTOR; PURINERGIC RECEPTOR STIMULATING AGENT; UNCLASSIFIED DRUG; URIDINE TRIPHOSPHATE; VISUAL PIGMENT;

ANIMAL EXPERIMENT; ARTICLE; BLOOD RETINA BARRIER; CELL MEMBRANE TRANSPORT; COMPARATIVE STUDY; DIFFERENTIAL VITREOUS FLUOROPHOTOMETRY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; DRUG SCREENING; FLUOROPHOTOMETRY; IN VIVO STUDY; MALE; NONHUMAN; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN TRANSPORT; STATISTICAL SIGNIFICANCE;

EID: 0344256501     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2003.09.014     Document Type: Article

References (41)

1. Bialek S., Joseph D.P., Miller S.S. The delayed basolateral membrane hyperpolarization of the bovine retinal pigment epithelium: mechanism of generation. J. Physiol. (Lond.). 484:1995;53-67.
2. Bird A.C. Retinal edema. Introduction to the first international cystoid macular edema symposium. Surv. Ophthalmol. 28:1984;433-436.
3. Blair N.P., Evans M.A., Lesar T.S., Zeimer R.C. Fluorescein and fluorescein glucuronide pharmacokinetics after intravenous injection. Invest. Ophthalmol. Vis. Sci. 27:1986;1107-1114.
4. Blair N.P., Zeimer R.C., Rusin M.M., Cunha-Vaz J.G. Outward transport of fluorescein from the vitreous in normal human subjects. Arch. Ophthalmol. 101:1983;1117-1121.
5. Bresnick G.H. Diabetic maculopathy. A critical review highlighting diffuse macular edema. Ophthalmology. 90:1983;1301-1317.
6. Burton T.C. Recovery of visual acuity after retinal detachment involving the macula. Trans. Am. Ophthalmol. Soc. 80:1982;475-497.
7. Chen S.C., Nakamura H., Tamura Z. Studies on the metabolites of fluorescein in rabbit and human urine. Chem. Pharm. Bull. 28:1980;1403-1407.
8. Cox S.N., Hay E., Bird A.C. Treatment of chronic macular edema with acetazolamide. Arch. Ophthalmol. 106:1988;1190-1195.
9. Cunha-Vaz J.G., Maurice D.M. The active transport of fluorescein by the retinal vessels and the retina. J. Physiol. 229:1967;350-357.
10. Cunha-Vaz J.G., Maurice D.M. Fluorescein dynamics in the eye. Doc. Ophthalmol. 26:1969;61-72.
11. Dick A.D. The treatment of chronic uveitic macular oedema. Is immunosuppression enough? Br. J. Ophthalmol. 78:1994;1-2.
12. Dubyak G.R. Signal transduction by P2-purinergic receptors for extracellular ATP. Am. J. Respir. Cell Mol. Biol. 4:1991;295-300.
13. Edelman J.L., Miller S.S. Epinephrine stimulates fluid absorption across bovine retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 32:1991;3033-3040.
14. Eguchi S., Araie M., Takase M. Movement of fluorescein and fluorescein glucronid across the isolated rabbit iris-ciliary body. Jpn. J. Ophthalmol. 31:1987;440-454.
15. Engler C.B., Sander B., Larsen L., Dalgaard P., Lund-Andersen H. Fluorescein transport across the human blood-retina barrier in the direction vitreous to blood. Quantitative assessment in vivo. Acta. Ophthalmol. (Copenh). 72:1994;655-662.
16. Grotte D., Mattox V., Brubaker R. Fluorescent, physiological and pharmacokinetic properties of fluorescein glucronide. Exp. Eye Res. 40:1985;23-33.
17. Joseph D.P., Miller S.S. Apical and Basal membrane ion transport mechanisms in bovine retinal pigment epithelium. J. Physiol. (Lond). 435:1991;439-463.
18. Kitano S., Nagataki S. Transport of fluorescein monoglucuronide out of vitreous. Invest. Ophthalmol. Vis. Sci. 27:1986;998-1001.
19. Koyano S., Araie M., Eguchi S. Movement of fluorescein and its glucuronide across retinal pigment epithelium-choroid. Invest. Ophthalmol. Vis. Sci. 34:1993;531-538.
20. Larsen L. Ocular fluorometry methodological improvements and clinical studies. Acta. Ophthalmol. (Copenh). 221:1993;1-52.
21. Larsen L., Dalgaard P., Lund-Andersen H. Differential spectrofluorometry in the human vitreous: blood-retinal barrier permeability to fluorescein and fluorescein glucronide. Graefes Arch. Clin. Exp. Ophthalmol. 229:1991;350-357.
22. Lund-Andersen H., Larsen M., Dalgaard P., Olsen W. Fluorescein and fluorescein glucuronide in the vitreous body of diabetic patients. Greafes Arch. Clin. Exp. Ophthalmol. 225:1987;173-176.
23. 2 receptor agonist INS37217 stimualtes RPE fluid transport in vitro and retinal reattachment in rat. Invest. Ophthalmol. Vis. Sci. 43:2002;3555-3566.
24. McLaren J., Brubaker R. Measurement of fluorescein and fluorescein glucuronide in the living human eye. Invest. Ophthalmol. Vis. Sci. 27:1986;966-974.
25. 2 receptor agonist, on experimental retinal detachment and electroretinogram in adult rabbits. Invest. Ophthalmol. Vis. Sci. 43:2002;3567-3574.
26. Moldow B., Sander B., Engler C.B., Larsen M., Rosenberg T., Lund-Andersen H. The effect of acetazolamide on leakage and outward active transport of fluorescein across the blood-retinal barrier inretinitis pigmentosa complicated by macular oedema. Greafes Arch. Clin. Exp. Ophthalmol. 236:1998;881-889.
27. Moldow B., Sander B., Larsen M., Lund-Andersen H. Effects of acetazolamide on passive and active transport of fluorescein across the normal BRB. Invest. Ophthalmol. Vis. Sci. 40:1999;1770-1775.
28. Mori F., Hikichi T., Takahashi J., Nagaoka T., Yoshida A. Dysfunction of active transport of blood retinal barrier in patients with clinically significant macular edema in type 2 diabetes mellitus. Diabetes Care. 25:2002;1248-1249.
29. Ogura Y., Tsukahara Y., Saito I., Kondo T. Estimation of the permeability of the blood-retina barrier in normal individuals. Invest. Ophthalmol. Vis. Sci. 26:1985;969-976.
30. Peterson W., Meggyesy C., Yu K., Miller S.S. Extracellular ATP activates calcium signaling, ion and fluid transport in retinal pigment epithelium. J. Neurosci. 17:1997;2324-2337.
31. Peterson W., Quong J.N., Miller S.S. Mechanism of fluid transport in retinal pigment epithelium. The Third Great Basin Visual Science Symposium on Retinal Research, 3. 1998;. pp. 34-42.
32. 2 receptor agonist, for the treatment of retinal detachment. Invest. Ophthalmol. Vis. Sci. 42:2001;446.
33. Plehwe W.E., Chahal P.S., Fallon T.J., Cunningham J.R., Neal M.J., Kohner E.M. Role of fluorescein glucuronide and its metabolism in vitreou fluorophotometry. Exp. Eye Res. 44:1987;209-225.
34. Ralevic V., Burnstock G. Receptors for purines and pyrimidines. Pharmacol. Rev. 50:1998;413-492.
35. Sander B., Larsen M., Moldow B., Lund-Andersen H. Diabetic macualr edema: passive and active transport of fluorescein through the blood-retina barrier. Invest. Ophthalmol. Vis. Sci. 42:2001;433-438.
36. Seto C., Araie M., Takase M. Study of fluorescein glucuronide. II. A comparative ocular kinetic study of fluorescein and fluorescein glucronide. Greafes Arch. Clin. Exp. Ophthalmol. 224:1986;113-117.
37. Shaver S.R., Douglass J.G., Brown E.G., Patel R.I., Redick C.L., Jones A.C., Boyer J.L., Picher M., Yerxa B.R. A comparison of mixed based dinucleotides versus same-base dinucleotides and their deoxyribo-analogues. XIV World Congress of Pharmacology poster 14611. 2002.
38. Takahashi J., Mori F., Hikichi T., Yoshida A. Effect of acetazolamide on outward permeability of blood-retina barrier using differential vitreous fluorophotometry. Curr. Eye Res. 23:2001;166-170.
39. Tani P., Robertson D.M., Langworthy A. Prognosis for central vision and anatomic reattachment in rhegmatogenous retinal detachment with macular detachment. Am. J. Ophthalmol. 92:1981;611-620.
40. Tsuboi S., Fujimoto T., Uchihori Y., Emi K., Iizuka S., Kishida K., Manabe R. Measurement of retinal permeability to sodium fluorescein in vitro. Invest. Ophthalmol. Vis. Sci. 25:1984;1146-1150.
41. Yoshida A., Ishiko S., Kojima M. Outward permeability of the blood-retinal barrier. Graefes Arch. Clin. Exp. Ophthalmol. 230:1992;78-83.